This inventor holds 1 USPTO granted patent. Top assignee: Agency for Science, Technology and Research. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Beihui Liu: Innovator in Gene Expression Technology
Introduction
Beihui Liu is a prominent inventor based in Singapore, known for his contributions to the field of gene expression in neuronal cells. With a focus on innovative solutions for gene therapy, Liu has made significant strides in understanding and enhancing gene expression mechanisms.
Latest Patents
Liu holds a patent for a chimeric promoter construct that is specifically designed for gene expression in neuronal cells. This invention relates to a recombinant nucleic acid molecule that includes a neuronal cell-specific promoter, such as the platelet-derived growth factor β-chain promoter, which is operably linked to a heterologous enhancer. This enhancer, like the cytomegalovirus immediate early gene enhancer, boosts the transcriptional activity of the promoter. The promoter construct developed by Liu can increase and prolong gene expression in neuronal cells, making it a valuable tool for gene therapy aimed at treating neuronal disorders. He has 1 patent to his name.
Career Highlights
Liu is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of biotechnology, particularly in applications related to neuroscience.
Collaborations
Liu collaborates with notable colleagues, including Shu Wang and Xu Wang, who contribute to his research initiatives and help drive innovation in their shared field.
Conclusion
Beihui Liu's innovative work in gene expression technology highlights his commitment to advancing scientific knowledge and therapeutic applications. His contributions are paving the way for future breakthroughs in the treatment of neuronal disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
